NovelStem International Corp. (NSTM)
OTCMKTS · Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
Jan 23, 2026, 4:00 PM EST
NovelStem International Revenue
NovelStem International had revenue of $3.00K in the twelve months ending September 30, 2025, down -75.00% year-over-year. In the year 2024, NovelStem International had annual revenue of $12.00K.
Revenue (ttm)
3.00K
Revenue Growth
-75.00%
P/S Ratio
287.54
Revenue / Employee
200.00
Employees
15
Market Cap
862.62K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.00K | - | - |
| Dec 31, 2023 | 12.00K | - | - |
| Dec 31, 2022 | 12.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 9.34M |
| T2 Biosystems | 7.68M |
| ProPhase Labs | 5.06M |
| Longduoduo Company | 4.15M |
| IDenta | 1.24M |
NovelStem International News
- 2 years ago - Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising - Newsfile Corp
- 3 years ago - NovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two Therapies - Newsfile Corp
- 3 years ago - NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial Update - Newsfile Corp
- 4 years ago - NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltd - Newsfile Corp